Taking care of cardiac device patients can be challenging. The BIOTRONIK remote monitoring system is designed to make this task easier and save time for everyone involved.
What if you could save time and improve patient outcomes?
Pairing and data transmission are fully automatic, allowing for easy “plug-and-go” setup and less patient interaction¹
Customize and personalize alerts remotely – and seamlessly integrate all data into your EHR system
In case of events, you can access actionable information right away – for well-informed decision-making and significant patient outcome improvements
From the beginning, BIOTRONIK Home Monitoring® combines ease of use with automaticity. This gives your patients a simple, no-hassle remote monitoring solution that offers successful data transmission and time savings for you2.
Set up BIOTRONIK Home Monitoring exactly how you need it. This unique remote cardiac monitoring system automatically transmits and verifies data and will alert you of gaps, so that you can react quickly.3 Benefit from smoother workflows, more personalized decisions, and more time for the patients that need you most.
BIOTRONIK Home Monitoring provides up-to-date and complete data sets and allows you to switch to alert-based care, saving you time and reducing your workload.
Taking care of cardiac device patients can be challenging. The BIOTRONIK remote monitoring system is designed to make this task easier and save time for everyone involved.
The BIOTRONIK Home Monitoring® system offers:
BIOTRONIK Home Monitoring is designed to save you time. Automatic pairing and reliable data transmission can significantly reduce time spent managing technological hurdles and ensuring patient compliance.
Automatic alert notification after 3 days* of no transmission ensures patient compliance to remote monitoring. (*user selectable)
Patient compliance with remote monitoring is particularly important for atrial fibrillation (AF) patients at risk for stroke – and heart failure patients who require continuous, long-term cardiac monitoring.
The IN-TIME approach Home Monitoring settings as recommended by the ESC Guidelines can be programmed in one single step
The programming does not need to be done in a face-to-face visit. All alert settings for cardiac monitoring can be set remotely, which reduces the workload for the staff significantly.
QuickView and Heart Failure Monitor compile all relevant data in a simple display – allowing you to see trends in data and make decisions based on the complete picture.
QuickView allows a fast insight into the status of patients with a pacemaker, ICD, CRT or ICM device.
BIOTRONIK places great emphasis on both easing clinician workload and high transmission success rates. With CardioMessenger's out-of-the-box functionality, clinicians experience reduced burdens during setup and troubleshooting, ensuring they can devote more time to personalized patient care.
Moreover, the high transmission success rate of 98%6 with our dedicated transmitter ensures that critical data reach healthcare professionals promptly and accurately, ultimately enhancing the effectiveness of cardiac rhythm management therapy.
Today's busiest clinics demand a faster, easier way to handle, store and process interrogated patient and device data. BIOTRONIK DataSync® exports data from BIOTRONIK Home Monitoring and BIOTRONIK programmers directly into a hospital's electronic health record. DataSysnc provides secure storage of patient data and paperless follow-up management.
Central storage makes the latest information of the alert-based cardiac care easily accessible by authorized health care professionals.
With the BIOTRONIK Patient App, your patients can be involved in the management of their condition and actively contribute to their remote cardiac monitoring.
The Patient App is designed for patients who have a BIOTRONIK cardiac device and are using BIOTRONIK Home Monitoring.
1. Symptom Diary to record and transmit symptom data to HMSC.
2. Digital Patient ID with device and hospital information.
3. Message function for a hospital contact request.
4. Home Monitoring data transmission feedback.
5. Daily status of device and battery.
6. Heart rhythm information measured by the device.
7. Education and help functions.
Start the video to learn more about the functionality of the BIOTRONIK Patient App.
Having symptom data in your HMSC, you can evaluate these symptoms in relation to the recorded events. This may result in making earlier fact-based therapy decisions.
The following devices are compatible with the BIOTRONIK Patient App:
Patients who have BIOTRONIK Home Monitoring can take full advantage of the functionality of the app.
In the HMSC, you can manage several functions of the Patient App for optimal use.
IN-TIME STUDY
60% mortality reduction; 30% reduction in worsening of clinical HF status
COMPAS STUDY
66% reduction in hospitalization for AF and related stroke
TRUST STUDY
60% less scheduled in-office visits required 45% less of in-office visits
VARMA ET AL.
81% reduction of non-actionable clinic visits
VARMA ET AL.
30% less patient attrition to follow-up
MARIANI ET AL.
98% data transmission success
ECOST
72% less hospitalizations due to inappropriate ICD shocks
BIOTRONIK DataSync simplifies the way patient information is stored and accessed at your hospital, saving time for you and your staff.
Data can automatically flow from BIOTRONIK devices to your data management system without any manual data entry required.
The built-in connectivity of BIOTRONIK patient devices and programmers enables data to flow automatically to the Home Monitoring Service Center (HMSC). Once in the cloud, all data is then sent to your system and accessible in one place.
BIOTRONIK DataSync is compatible with existing IT setups and complies with international standards.
All patient data flows automatically from the implanted device to the electronic health record. The data is transmitted via the CardioMessenger Smart for remote patients and via ReportShare during in-office visits. The EHR DataSync Adapter connects the data from the Home Monitoring Service Center to the hospital data system.
BIOTRONIK complies with interoperability standards IEEE/HL7 IDCO, as well as the latest cybersecurity standards. In this way, BIOTRONIK DataSync is compatible with existing standards at your hospital.
The first step is to make an appointment with your BIOTRONIK representative or fill in the contact form on this website. The BIOTRONIK specialist will explain BIOTRONIK DataSync in detail to you or your IT specialist. Together, an implementation plan is created, and when everyone agrees, the implementation can get underway.
With the BIOTRONIK Patient App, your patients can be involved in the management of their condition...
The mobile CardioMessenger Smart looks like a smartphone and can be used on the go for up to 48...
Every year, more and more patients are receiving ICMs — all of which must be actively managed...
Physicians working with ICMs generally have a very heavy workload and false positive AF detections...
Heart failure is a leading cause of hospitalizations, and each hospitalization reflects a...
1. Ricci RP et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace. 2010;12(5):674–9; 2. Mariani JA et al. Miniaturized implantable cardiac monitor with a long sensing vector (BIOMONITOR III): Insertion procedure assessment, sensing performance, and home monitoring transmission successJournal of Electrocardiology 60 (2020) 118–125; 3. Hindricks G et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomized controlled trial. The Lancet. 2014; 384 (9943): 583–590.; 4. Varma N et al. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial. Circulation, 2010;122: 325 – 332.; 5. Varma N, et al. Alert-Based ICD Follow-Up. JACC: Clinical Electrophysiology. 2021;76(Suppl 1):1363. doi: 10.1016/j. jacep.2021.01.008.; 6. Mabo P et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J.2012;33(9):1105–11.
